Teacher Retirement System of Texas Has $51.49 Million Stock Holdings in CVS Health Corporation $CVS

Teacher Retirement System of Texas lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 97.0% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 682,987 shares of the pharmacy operator’s stock after buying an additional 336,333 shares during the period. Teacher Retirement System of Texas’ holdings in CVS Health were worth $51,490,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of CVS. Flagship Wealth Advisors LLC increased its holdings in CVS Health by 67.0% in the 3rd quarter. Flagship Wealth Advisors LLC now owns 581 shares of the pharmacy operator’s stock valued at $44,000 after buying an additional 233 shares during the period. Naples Global Advisors LLC raised its position in CVS Health by 2.8% during the third quarter. Naples Global Advisors LLC now owns 8,246 shares of the pharmacy operator’s stock valued at $622,000 after purchasing an additional 221 shares in the last quarter. Strs Ohio lifted its stake in CVS Health by 24.6% during the third quarter. Strs Ohio now owns 1,043,250 shares of the pharmacy operator’s stock worth $78,651,000 after purchasing an additional 205,718 shares during the last quarter. Woodard & Co. Asset Management Group Inc. ADV boosted its holdings in shares of CVS Health by 15.1% in the 3rd quarter. Woodard & Co. Asset Management Group Inc. ADV now owns 28,383 shares of the pharmacy operator’s stock valued at $2,140,000 after purchasing an additional 3,721 shares in the last quarter. Finally, CNB Bank raised its holdings in shares of CVS Health by 21.3% during the 3rd quarter. CNB Bank now owns 1,179 shares of the pharmacy operator’s stock worth $89,000 after buying an additional 207 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on CVS shares. Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Truist Financial set a $100.00 price target on shares of CVS Health in a report on Wednesday, December 10th. TD Cowen upped their price objective on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Finally, Royal Bank Of Canada reiterated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $94.86.

CVS Health Price Performance

Shares of NYSE:CVS opened at $82.65 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a 52 week low of $52.69 and a 52 week high of $85.15. The firm has a market cap of $104.92 billion, a PE ratio of 217.51, a price-to-earnings-growth ratio of 0.75 and a beta of 0.48. The firm’s fifty day moving average is $78.95 and its 200-day moving average is $74.62.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the previous year, the company posted $1.09 EPS. The business’s revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be given a $0.665 dividend. The ex-dividend date is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. CVS Health’s payout ratio is 700.00%.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Large bullish options activity: Unusually heavy call buying — about 37,560 calls in a single session (roughly +59% vs. average) — signals short‑term investor optimism and could support upward price momentum. Investors Buy Large Volume of CVS Health Call Options (NYSE:CVS)
• Positive Sentiment: Operational changes to ease utilization and share savings: CVS announced cuts to prior authorizations and an expansion of rebate‑sharing—moves that can reduce friction for providers and patients and potentially improve script flow and client relationships. CVS Health cuts prior authorizations, expands rebate sharing
• Positive Sentiment: Business growth and innovation initiatives: Announcements on making health insurance “simpler and more affordable” and a university partnership for AI and pharmacy workforce development support long‑term growth and cost efficiency narratives. CVS Health® makes health insurance simpler and more affordable for Americans CVS Health, U of Maryland partner on AI, pharmacy workforce growth
• Neutral Sentiment: Legal developments mixed: Bloomberg Law reports CVS and UnitedHealth successfully fended off a specific antitrust lawsuit over drug costs — a legal win that reduces near‑term tail risk but does not eliminate broader regulatory scrutiny. UnitedHealth, CVS Fend Off Antitrust Lawsuit Over Drug Costs
• Negative Sentiment: Congressional antitrust findings and sustained PBM scrutiny: A House Judiciary Committee report and related coverage accuse CVS/Caremark of impeding competition and targeting independent pharmacies; lawmakers have flagged potential antitrust violations and executives were grilled in hearings—this political and regulatory pressure raises the risk of fines, remedies, or changes to PBM practices that could hurt margins. House Judiciary Committee Report Accuses CVS Health of Thwarting Competition and Targeting Independent Pharmacies House committee accuses CVS of impeding pharmacy competition CVS faces antitrust scrutiny over PBM practices

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.